Lawyers from DLA Piper’s Life Sciences team – Veronika Appl (Austria), Petr Samec (Czech Republic), Andrzej Balicki and Jolanta Dąbrowicz (Poland), Irina Macovei, and Amalia Musat (Romania) – have shared their insights on the advertising of medical devices in CEE in an interview with CEE Legal Matters. 

The discussion highlighted the distinct regulatory landscapes in each country and identified key focus areas for the Life Sciences sector moving forward. The advertising of medical devices is becoming an increasingly significant issue across the CEE region. Our lawyers discussed the similarities and differences in a number of jurisdictions, as well as various trends that can be observed. They also highlighted the importance of developing complex, cross-border strategies for both basic medical devices and advanced digital tools. The rapid rise of digital medical devices, accelerated by the COVID-19 pandemic, has also focused attention on data protection and evolving advertising standards.

The full interview will be available soon. In the meantime, you can check out the comparison guide developed by our CEE Life Sciences team. This is a multi-jurisdictional guide on the advertising of medical devices in CEE that offers a clearer path for businesses operating in the region and helps them to navigate the diverse legal landscapes.

Download the guide here.